Search Results

Cleantech Blue-Zone Technologies Signs Agreement With Class 1

Blue-Zone Technologies Ltd. announced it has signed a definitive collaboration agreement with Class 1 Incorporated, Canada’s leading medical gas and centralized anesthetic capture equipment manufacturer, distributor and service provider.

November 1, 2023

·

3 min read

Cleantech Blue-Zone Technologies Signs Agreement With Respirair Global

Blue-Zone Technologies Ltd. announced it has signed an agreement with Respirair Global LLC to install its patented capture technology in Respirair’s manufacturing facility.

April 11, 2023

·

2 min read

Cleantech Blue-Zone Technologies Signs Letter of Intent with Leading Medical Gas Equipment Manufacturer, Class 1Parties consider collaborative agreement for the collection and conversion of anesthetic gases

Blue-Zone Technologies Ltd. announced it has signed a letter of intent with Canada’s leading medical gas equipment manufacturer, distributor and service provider, Class 1 Incorporated.

June 19, 2023

·

3 min read

Press Releases

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies

October 30, 2024

·

5 min read

Blue-Zone Technologies, Ltd. Secures $8 Million of Institutional Financing

Blue-Zone Technologies, Ltd. resulting in the production of branded generic anesthetics, is proud to announce an $8 million round of institutional financing jointly led by the Canadian Venture Capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC.

October 4, 2022

·

5 min read

Business

SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.

June 6, 2024

·

3 min read

FDA

Blue Arbor Technologies Receives FDA Breakthrough Device Designation and TAP Enrollment for the RESTORE™ Neuromuscular Interface System

Blue Arbor Technologies Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the RESTORE™ Neuromuscular Interface System for people with upper limb loss.

April 24, 2024

·

6 min read

Press Releases

WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024

November 28, 2024

·

4 min read

BioMidwest

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.

March 4, 2024

·

3 min read

Pharm Country

Blue Earth Diagnostics Highlights Presentations on POSLUMA®

Blue Earth Diagnostics Highlights Presentations on POSLUMA® at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held June 8 to 11, 2024, in Toronto, Canada.

May 29, 2024

·

10 min read